Beloqui A - Search Results

1

Poly-ɛ-caprolactone nanocapsules loaded with copaiba essential oil reduce inflammation and pain in mice.

Pinto EP, da Costa SOAM, D'Haese C, Nysten B, Machado FP, Rocha LM, de Souza TM, Beloqui A, Machado RR, Araújo RS. Pinto EP, et al. Among authors: beloqui a. Int J Pharm. 2023 Jul 25;642:123147. doi: 10.1016/j.ijpharm.2023.123147. Epub 2023 Jun 17. Int J Pharm. 2023. PMID: 37336298

2

Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V. Beloqui A, et al. J Control Release. 2013 Mar 10;166(2):115-23. doi: 10.1016/j.jconrel.2012.12.021. Epub 2012 Dec 22. J Control Release. 2013. PMID: 23266764

3

Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors.

Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez-Gascón A. Beloqui A, et al. Eur J Pharm Biopharm. 2013 Jun;84(2):309-14. doi: 10.1016/j.ejpb.2013.01.029. Epub 2013 Feb 24. Eur J Pharm Biopharm. 2013. PMID: 23461861

4

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.

Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Préat V. Beloqui A, et al. Int J Pharm. 2014 Oct 1;473(1-2):203-12. doi: 10.1016/j.ijpharm.2014.07.009. Epub 2014 Jul 8. Int J Pharm. 2014. PMID: 25014369

5

Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease.

Guada M, Beloqui A, Alhouayek M, Muccioli GG, Dios-Viéitez Mdel C, Préat V, Blanco-Prieto MJ. Guada M, et al. Among authors: beloqui a. Int J Pharm. 2016 Apr 30;503(1-2):196-8. doi: 10.1016/j.ijpharm.2016.03.012. Epub 2016 Mar 10. Int J Pharm. 2016. PMID: 26972380

6

Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases.

Plaza-Oliver M, Beloqui A, Santander-Ortega MJ, Castro-Vázquez L, Rodríguez-Robledo V, Arroyo-Jiménez MM, Préat V, Lozano MV. Plaza-Oliver M, et al. Among authors: beloqui a. Int J Pharm. 2020 Aug 30;586:119533. doi: 10.1016/j.ijpharm.2020.119533. Epub 2020 Jun 11. Int J Pharm. 2020. PMID: 32534160

7

Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis.

Huguet-Casquero A, Xu Y, Gainza E, Pedraz JL, Beloqui A. Huguet-Casquero A, et al. Among authors: beloqui a. Int J Pharm. 2020 Aug 30;586:119515. doi: 10.1016/j.ijpharm.2020.119515. Epub 2020 Jun 13. Int J Pharm. 2020. PMID: 32544520

8

"Green" synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics.

Kambale EK, Domingues I, Zhang W, Marotti V, Chen C, Hughes K, Quetin-Leclercq J, Memvanga PB, Beloqui A. Kambale EK, et al. Among authors: beloqui a. Int J Pharm. 2024 Jan 25;650:123701. doi: 10.1016/j.ijpharm.2023.123701. Epub 2023 Dec 10. Int J Pharm. 2024. PMID: 38081556

9

Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.

Beloqui A, Coco R, Alhouayek M, Solinís MÁ, Rodríguez-Gascón A, Muccioli GG, Préat V. Beloqui A, et al. Int J Pharm. 2013 Oct 1;454(2):775-83. doi: 10.1016/j.ijpharm.2013.05.017. Epub 2013 May 18. Int J Pharm. 2013. PMID: 23694806

10

Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.

Beloqui A, Solinís MÁ, des Rieux A, Préat V, Rodríguez-Gascón A. Beloqui A, et al. Int J Pharm. 2014 Jul 1;468(1-2):105-11. doi: 10.1016/j.ijpharm.2014.04.027. Epub 2014 Apr 16. Int J Pharm. 2014. PMID: 24746410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters